Illumina News and Research

RSS
The Evolution of Plant Cell Analysis with RevGel-seq Technique

The Evolution of Plant Cell Analysis with RevGel-seq Technique

New State-of-the-Art Genomic Services Facility Opening in the UK

New State-of-the-Art Genomic Services Facility Opening in the UK

Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development and Commercialization

Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development and Commercialization

Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences Closes $15M Series A Funding Round

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

Unchained Labs Adds Big-Time Horsepower with New CCO

Unchained Labs Adds Big-Time Horsepower with New CCO

New Computational Methods for Improving Alzheimer’s Disease Characterization

New Computational Methods for Improving Alzheimer’s Disease Characterization

Understanding Potential Mechanisms Underlying Genetic Variation in Older Trees

Understanding Potential Mechanisms Underlying Genetic Variation in Older Trees

Researchers Generate the Most Complete Catalog of Genomic Information About Primates

Researchers Generate the Most Complete Catalog of Genomic Information About Primates

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Study Reveals an Immunological Strategy to Overcome Microbiome-Related Immunotherapy Resistance

Study Reveals an Immunological Strategy to Overcome Microbiome-Related Immunotherapy Resistance

High-quality genome of a deep-sea eel illuminates the molecular mechanisms of deep-sea adaptation

High-quality genome of a deep-sea eel illuminates the molecular mechanisms of deep-sea adaptation

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Newly sequenced Honeycrisp apple genome could be a boon for scientists and breeders

Newly sequenced Honeycrisp apple genome could be a boon for scientists and breeders

An inventory of human genetic variation through upgrading the 1000 genomes project resource

An inventory of human genetic variation through upgrading the 1000 genomes project resource

Researchers propose a solution to delayed molecular diagnosis and therapy in childhood genetic diseases

Researchers propose a solution to delayed molecular diagnosis and therapy in childhood genetic diseases

Integrating Science, Software, and Data to Accelerate Antibody Discovery

Integrating Science, Software, and Data to Accelerate Antibody Discovery

Study shows how genetic database offers strong implications for chimpanzee conservation

Study shows how genetic database offers strong implications for chimpanzee conservation

New vaccine providing protection against future animal-to-human viral diseases may be possible

New vaccine providing protection against future animal-to-human viral diseases may be possible

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.